<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00120289</url>
  </required_header>
  <id_info>
    <org_study_id>226</org_study_id>
    <secondary_id>U01HL081649</secondary_id>
    <secondary_id>U01HL081616</secondary_id>
    <nct_id>NCT00120289</nct_id>
  </id_info>
  <brief_title>Niacin Plus Statin to Prevent Vascular Events</brief_title>
  <official_title>AIM HIGH: Niacin Plus Statin to Prevent Vascular Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Axio Research. LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Axio Research. LLC</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether raising &quot;good cholesterol&quot; with a drug
      based on the vitamin niacin, while lowering &quot;bad cholesterol&quot; with a statin drug, can prevent
      more heart disease than the statin alone.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Coronary heart disease (CHD) remains the leading cause of death and disability in the Western
      world, with approximately 12.6 million individuals in the United States having a history of
      myocardial infarction (MI), angina, or both. There is mounting evidence that &quot;conventional&quot;
      therapies aimed at traditional risk factors have not optimized clinical outcomes. For
      example, in the Heart Protection Study with 20,536 subjects, the 5-year risk of a first major
      vascular event (nonfatal MI or CHD death, stroke, or coronary or noncoronary
      revascularization) among placebo-treated patients was 25%. Treatment with simvastatin reduced
      this risk to 20% over 5 years, which would project out to a 10-year risk of 40%. (The
      National Cholesterol Education Program Adult Treatment Panel III considers &quot;high risk&quot; or CHD
      equivalent a 10-year risk of an event greater than 20%.) Even among patients entering the
      study with baseline low density lipoprotein cholesterol (LDL-C) already near or at goal
      (i.e., LDL-C less than 116 mg/dL) and who achieved a mean on-trial LDL-C of 70 mg/dL with
      simvastatin, the 5-year risk of an event was still 18% (projecting to a 10-year risk of 36%).
      This residual and unacceptably high risk is likely due to the increasing prevalence of
      obesity, type II diabetes mellitus, and the metabolic syndrome. These disorders are typically
      accompanied by a constellation of abnormalities that include impaired glycemic control,
      hypertension, procoagulant and inflammatory states, and atherogenic dyslipidemia. The latter
      includes a wide spectrum of lipid abnormalities (low HDL-C, high triglycerides and
      triglyceride-rich remnant lipoproteins, and a preponderance of small dense, highly-oxidizable
      LDL particles).

      Conventional LDL-C-focused therapies are not effective in targeting this type of
      dyslipidemia. Evidence that therapy directed at atherogenic dyslipidemia among patients with
      CHD can lower outcomes was shown with gemfibrozil in the VA-HIT trial, which showed a 22 to
      24% cardiovascular (CV) event reduction by raising HDL-C (by an average of 6%) and lowering
      triglycerides (by an average of 31%). Niacin is an even more effective agent for
      simultaneously raising HDL-C and lowering triglycerides and levels of small dense LDL, and
      holds the most promise among existing therapies for substantial risk reduction in this
      population when added to a statin. This was demonstrated in the HDL Atherosclerosis Treatment
      Study (HATS) trial in which atherosclerosis progression was virtually halted and CV events
      were reduced by 60 to 90% using combined niacin plus statin therapy.

      DESIGN NARRATIVE:

      AIM-HIGH is a multicenter, randomized, double-blind, parallel-group, controlled clinical
      trial designed to test whether the drug combination of extended release niacin plus
      simvastatin is superior to simvastatin alone, at comparable levels of on-treatment LDL-C, for
      delaying the time to a first major CV disease outcome over a 4-year median follow-up in
      patients with atherogenic dyslipidemia. Prior clinical trials have found only 25 to 35% CV
      risk reduction using statin monotherapy (i.e., event rate 2/3 to 3/4 of placebo rate). The
      study is needed to confirm whether statin-niacin combination therapy, designed to target a
      wider spectrum of dyslipidemic factors in addition to LDL-C, will provide a more substantial
      (greater than 50%) reduction of CV events. Epidemiologic studies confirm the high prevalence
      of atherogenic dyslipidemia and its impact on CV event rates. Preliminary clinical trials
      suggest that targeting these factors with dyslipidemic therapy will reduce CV events. The
      study will enroll an estimated 3,300 men and women more than 45 years old at high risk of
      recurrent CV events by virtue of having established CV disease together with the two
      dyslipidemic elements of metabolic syndrome: low HDL-cholesterol (HDL-C) (less than or equal
      to 40 mg/dl) and high triglycerides (TG) (greater than or equal to 150 mg/dl). The study
      specifically aims to test this hypothesis for the primary composite clinical end point of CHD
      death, nonfatal MI, ischemic stroke, hospitalization for acute coronary syndrome with
      objective evidence of ischemia (troponin-positive or ST-segment deviation), or symptom-driven
      coronary or cerebral revascularization. Secondary end points include the composite of CHD
      death, nonfatal MI, ischemic stroke, or hospitalization for high-risk acute coronary
      syndrome; the composite of CHD death, nonfatal MI or ischemic stroke; and cardiovascular
      mortality.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in
    preventing primary outcome events.
  </why_stopped>
  <start_date>September 2005</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite End Point of CHD Death, Nonfatal MI, Ischemic Stroke, Hospitalization for Non-ST Segment Elevation Acute Coronary Syndrome (ACS), or Symptom-driven Coronary or Cerebral Revascularization</measure>
    <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Composite Endpoint of CHD Death, Non-fatal MI, High-risk ACS or Ischemic Stroke</measure>
    <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite Endpoint of CHD Death, Non-fatal MI, or Ischemic Stroke</measure>
    <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Mortality</measure>
    <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination), for an average of 36 months follow-up, maximum 66 months.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3414</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Cerebrovascular Accident</condition>
  <condition>Coronary Disease</condition>
  <condition>Atherosclerosis</condition>
  <condition>Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Combination Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Extended release niacin plus simvastatin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Monotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Simvastatin alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Extended release niacin</intervention_name>
    <description>2,000 mg/day or 1,500 mg/day if higher dose not tolerated</description>
    <arm_group_label>Combination Therapy</arm_group_label>
    <other_name>Niaspan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Simvastatin</intervention_name>
    <description>Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
    <arm_group_label>Combination Therapy</arm_group_label>
    <arm_group_label>Monotherapy</arm_group_label>
    <other_name>Zocor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and women aged 45 and older with established vascular disease and atherogenic
             dyslipidemia

          -  Established vascular disease defined as one or more of the following: (1) documented
             coronary artery disease (CAD); (2) documented cerebrovascular or carotid disease; (3)
             documented symptomatic peripheral arterial disease (PAD)

          -  Atherogenic dyslipidemia defined as: (1) LDL-C of less than or equal to 160 mg/dL (4.1
             mmol/L); (2) HDL-C of less than or equal to 40 mg/dL (1.0 mmol/L) for men or less than
             or equal to 50 mg/dL (1.3 mmol/L) for women; (3) TG greater than or equal to 150 mg/dL
             (1.7 mmol/L) and less than or equal to 400 mg/dL (4.5 mmol/L)

          -  For patients entering the trial on a statin: (1) the upper limit for LDL-C is adjusted
             according to the specific statin and statin dose; (2) HDL-C of less than or equal to
             42 mg/dL (1.1 mmol/L) for men or less than or equal to 53 mg/dL (1.4 mmol/L) for
             women; (3) TG greater than or equal to 125 mg/dL (1.4 mmol/L) and less than or equal
             to 400 mg/DL (4.5 mmol/L)

        Exclusion Criteria:

          -  Coronary artery bypass graft (CABG) surgery within 1 year of planned enrollment
             (run-in phase)

          -  Percutaneous coronary intervention (PCI) within 4 weeks of planned enrollment (run-in
             phase)

          -  Hospitalization for acute coronary syndrome and discharge within 4 weeks of planned
             enrollment (run-in phase)

          -  Fasting glucose greater than 180 mg/dL (10 mmol/L) or hemoglobin A1C greater than 9%

          -  For patients with diabetes, inability or refusal to use a glucometer for home
             monitoring of blood glucose

          -  Concomitant use of drugs with a high probability of increasing the risk for
             hepatotoxicity or myopathy, such as those predominantly metabolized by cytochrome P450
             system 3A4, including but not limited to cyclosporine, gemfibrozil, fenofibrate,
             itraconazole, ketoconazole, HIV protease inhibitors, nefazodone, verapamil,
             amiodarone; lipid-lowering drugs (other than the investigational drugs) such as
             statins, bile-acid sequestrants, cholesterol absorption inhibitors (e.g., ezetimibe),
             fibrates or high-dose, antioxidant vitamins (vitamins C, E, or beta carotene) that can
             interfere with the HDL-raising effect of niacin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruth McBride</last_name>
    <role>Study Director</role>
    <affiliation>Axio Research Corporation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William E. Boden, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samuel S. Stratton VA Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeffrey Probstfield, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Associates, P.C.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Alabama, Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinical Research Consultants, Inc.</name>
      <address>
        <city>Hoover</city>
        <state>Alabama</state>
        <zip>35216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carl T. Hayden VAMC Phoenix Medical Service</name>
      <address>
        <city>Pheonix</city>
        <state>Arizona</state>
        <zip>85012</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Consultants Ltd</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diabetes Center of Excellence</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Clinical Research (Eastside Site)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tucson Clinical Research (Northwest Site)</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85741</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Arkansas</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Saint Joseph Medical Center</name>
      <address>
        <city>Burbank</city>
        <state>California</state>
        <zip>91505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Long Beach Healthcare System</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90822</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Holy Cross Medical Center</name>
      <address>
        <city>Mission Hills</city>
        <state>California</state>
        <zip>91345</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart &amp; Vascular Research Center</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>James A. Haley Veteran's Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Idaho State University</name>
      <address>
        <city>Pocatello</city>
        <state>Idaho</state>
        <zip>83201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Research Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center, P.C.</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50314</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lipid Research Clinic, University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maine Center for Lipids &amp; Cardiovascular Health</name>
      <address>
        <city>Scarborough</city>
        <state>Maine</state>
        <zip>04074</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pentucket Medical Associates</name>
      <address>
        <city>Haverhill</city>
        <state>Massachusetts</state>
        <zip>01830</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Veterans Affairs Health System of Ann Arbor, Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grunberger Diabetes Institute</name>
      <address>
        <city>Bloomfield Hills</city>
        <state>Michigan</state>
        <zip>48302</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Berman Center for Outcomes and Clinical Research</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthPartners Riverside Clinic</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55454</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phalen Village Clinic</name>
      <address>
        <city>St. Paul</city>
        <state>Minnesota</state>
        <zip>55106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Twin Cities</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>G.V. (Sonny) Montgomery VAMC</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Louis University</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alegent Health Heart &amp; Vascular Specialists</name>
      <address>
        <city>Papillion</city>
        <state>Nebraska</state>
        <zip>68046</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper Clinical Trials Center</name>
      <address>
        <city>Cherry Hill</city>
        <state>New Jersey</state>
        <zip>08034</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of the Delaware Valley</name>
      <address>
        <city>Elmer</city>
        <state>New Jersey</state>
        <zip>08318</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMDNJ -Robert Wood Johnson Medical School</name>
      <address>
        <city>New Brunswick</city>
        <state>New Jersey</state>
        <zip>08903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Mexico VA Healthcare Systems</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaleida Health/Diabetes Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mid Valley Cardiology</name>
      <address>
        <city>Kingston</city>
        <state>New York</state>
        <zip>12401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA New York Harbor Healthcare System</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Syracuse Preventive Cardiology</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University - Geriatrics/Gerontology</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences - Department of Cardiology</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University School of Medicine - Internal Medicine/Endocrinology</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sterling Research Group, Ltd.</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St Vincent Charity Hospital - The Center for Vascular Health</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Ohio Research, Ltd.</name>
      <address>
        <city>Sandusky</city>
        <state>Ohio</state>
        <zip>44870</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Portland VA Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Philadelphia VA Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennsylvania Cardiology Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19148</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Women's Cardiac Center at The Miriam Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Internal Medicine Associates of Greenville</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VAMC Memphis - Hypertension/Lipid Research Clinic</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kelsey Research Foundation</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Virginia - UVA Cardiology</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McGuire VA Medical Center</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington, Northwest Lipid Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washington, Coronary Atherosclerosis Research Lab</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VA Cardiology Research</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington State University</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CARE Foundation, Inc.</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Health Institute</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2E 7C5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foothills Medical Centre</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 2T9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Alexandra Hospital</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T5H 3V9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vancouver Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V5Z 1M9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Heart Institute</name>
      <address>
        <city>Victoria</city>
        <state>British Columbia</state>
        <zip>V8R 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Sciences Center, Diabetes Research Group</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3E 3R4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Brunswick Heart Center</name>
      <address>
        <city>St John</city>
        <state>New Brunswick</state>
        <zip>E2L 4L2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial University of Newfoundland</name>
      <address>
        <city>St. John's</city>
        <state>Newfoundland and Labrador</state>
        <zip>A1B 3V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth II Health Sciences Center</name>
      <address>
        <city>Halifax</city>
        <state>Nova Scotia</state>
        <zip>B3H 3A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates VRH</name>
      <address>
        <city>Kentville</city>
        <state>Nova Scotia</state>
        <zip>B4N 5E3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cambridge Cardiac Care Center</name>
      <address>
        <city>Cambridge</city>
        <state>Ontario</state>
        <zip>N1R 6V6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McConnell Medical Center</name>
      <address>
        <city>Cornwall</city>
        <state>Ontario</state>
        <zip>K6H 4M4</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamilton Health Sciences - General Site</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8L 2X2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LHSC University Hospital</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N6A 5A5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Newmarket Cardiology Research Group</name>
      <address>
        <city>Newmarket</city>
        <state>Ontario</state>
        <zip>L3Y 8C3</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sudbury Cardiovascular Research</name>
      <address>
        <city>Sudbury</city>
        <state>Ontario</state>
        <zip>P3E 2N8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Michael's Hospital Health Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5C 2T2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de Cardiologie de Lévis</name>
      <address>
        <city>Lévis</city>
        <state>Quebec</state>
        <zip>G6V 4Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique des maladies lipidiques de Québec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4M6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CSSS Beauce</name>
      <address>
        <city>St-Georges de Beauce</city>
        <state>Quebec</state>
        <zip>G5Y 4T8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CSSS du Sud de Lanaudière - Hôpital Pierre-Le Gardeur</name>
      <address>
        <city>Terrebonne</city>
        <state>Quebec</state>
        <zip>J6V 2H2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Recherches Clinicar</name>
      <address>
        <city>Quebec</city>
        <zip>G1J 1Z6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.aimhigh-heart.com/</url>
    <description>AIM-HIGH Web site for patients</description>
  </link>
  <reference>
    <citation>AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol: baseline characteristics of study participants. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: impact on Global Health outcomes (AIM-HIGH) trial. Am Heart J. 2011 Mar;161(3):538-43. doi: 10.1016/j.ahj.2010.12.007. Epub 2011 Feb 2.</citation>
    <PMID>21392609</PMID>
  </reference>
  <reference>
    <citation>AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2. doi: 10.1016/j.ahj.2010.11.017. Epub 2011 Feb 2.</citation>
    <PMID>21392600</PMID>
  </reference>
  <results_reference>
    <citation>AIM-HIGH Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011 Dec 15;365(24):2255-67. doi: 10.1056/NEJMoa1107579. Epub 2011 Nov 15. Erratum in: N Engl J Med. 2012 Jul 12;367(2):189.</citation>
    <PMID>22085343</PMID>
  </results_reference>
  <results_reference>
    <citation>Teo KK, Goldstein LB, Chaitman BR, Grant S, Weintraub WS, Anderson DC, Sila CA, Cruz-Flores S, Padley RJ, Kostuk WJ, Boden WE; AIM-HIGH Investigators. Extended-release niacin therapy and risk of ischemic stroke in patients with cardiovascular disease: the Atherothrombosis Intervention in Metabolic Syndrome with low HDL/High Triglycerides: Impact on Global Health Outcome (AIM-HIGH) trial. Stroke. 2013 Oct;44(10):2688-93. doi: 10.1161/STROKEAHA.113.001529. Epub 2013 Jul 23.</citation>
    <PMID>23881958</PMID>
  </results_reference>
  <results_reference>
    <citation>Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO Jr, Xu P, Marcovina SM. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013 Oct 22;62(17):1575-9. doi: 10.1016/j.jacc.2013.06.051. Epub 2013 Aug 21.</citation>
    <PMID>23973688</PMID>
  </results_reference>
  <results_reference>
    <citation>Guyton JR, Slee AE, Anderson T, Fleg JL, Goldberg RB, Kashyap ML, Marcovina SM, Nash SD, O'Brien KD, Weintraub WS, Xu P, Zhao XQ, Boden WE. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes). J Am Coll Cardiol. 2013 Oct 22;62(17):1580-4. doi: 10.1016/j.jacc.2013.07.023. Epub 2013 Jul 31.</citation>
    <PMID>23916935</PMID>
  </results_reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2005</study_first_submitted>
  <study_first_submitted_qc>July 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2005</study_first_posted>
  <results_first_submitted>June 1, 2015</results_first_submitted>
  <results_first_submitted_qc>June 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 17, 2015</results_first_posted>
  <last_update_submitted>March 8, 2016</last_update_submitted>
  <last_update_submitted_qc>March 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Axio Research. LLC</investigator_affiliation>
    <investigator_full_name>Ruth McBride</investigator_full_name>
    <investigator_title>Co-Director, Coordinating Center</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simvastatin</mesh_term>
    <mesh_term>Niacin</mesh_term>
    <mesh_term>Niacinamide</mesh_term>
    <mesh_term>Nicotinic Acids</mesh_term>
  </intervention_browse>
  <study_docs>
    <study_doc>
      <doc_id>AIM-HIGH</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>http://biolincc.nhlbi.nih.gov/studies/aimhigh/</doc_url>
      <doc_comment>NHLBI provides controlled access to IPD through BioLINCC. Access requires registration, evidence of local IRB approval or certification of exemption from IRB review, and completion of a data use agreement.</doc_comment>
    </study_doc>
    <study_doc>
      <doc_id>AIM-HIGH</doc_id>
      <doc_type>Study Protocol</doc_type>
      <doc_url>http://biolincc.nhlbi.nih.gov/studies/aimhigh/</doc_url>
    </study_doc>
    <study_doc>
      <doc_id>AIM-HIGH</doc_id>
      <doc_type>Study forms</doc_type>
      <doc_url>http://biolincc.nhlbi.nih.gov/studies/aimhigh/</doc_url>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ERN + Simvastatin</title>
          <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
        <group group_id="P2">
          <title>Placebo + Simvastatin</title>
          <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1718"/>
                <participants group_id="P2" count="1696"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1597"/>
                <participants group_id="P2" count="1587"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="121"/>
                <participants group_id="P2" count="109"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="96"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Intention-to-treat</population>
      <group_list>
        <group group_id="B1">
          <title>ERN + Simvastatin</title>
          <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
        <group group_id="B2">
          <title>Placebo + Simvastatin</title>
          <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1718"/>
            <count group_id="B2" value="1696"/>
            <count group_id="B3" value="3414"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="917"/>
                    <measurement group_id="B2" value="915"/>
                    <measurement group_id="B3" value="1832"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="801"/>
                    <measurement group_id="B2" value="781"/>
                    <measurement group_id="B3" value="1582"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63.7" spread="8.8"/>
                    <measurement group_id="B2" value="63.7" spread="8.7"/>
                    <measurement group_id="B3" value="63.7" spread="8.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="253"/>
                    <measurement group_id="B2" value="251"/>
                    <measurement group_id="B3" value="504"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1465"/>
                    <measurement group_id="B2" value="1445"/>
                    <measurement group_id="B3" value="2910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="140"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1654"/>
                    <measurement group_id="B2" value="1619"/>
                    <measurement group_id="B3" value="3273"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1572"/>
                    <measurement group_id="B2" value="1576"/>
                    <measurement group_id="B3" value="3148"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1179"/>
                    <measurement group_id="B2" value="1167"/>
                    <measurement group_id="B3" value="2346"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Canada</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="539"/>
                    <measurement group_id="B2" value="529"/>
                    <measurement group_id="B3" value="1068"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lipids and Lipoproteins at Baseline</title>
          <units>mg/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>LDL-C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.2" spread="23.4"/>
                    <measurement group_id="B2" value="74.0" spread="22.7"/>
                    <measurement group_id="B3" value="74.1" spread="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL-C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.5" spread="5.6"/>
                    <measurement group_id="B2" value="34.9" spread="5.6"/>
                    <measurement group_id="B3" value="34.7" spread="5.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Triglycerides</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="183.5" spread="66.7"/>
                    <measurement group_id="B2" value="181.9" spread="66.9"/>
                    <measurement group_id="B3" value="182.7" spread="66.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>non-HDL cholesterol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="110.8" spread="27.5"/>
                    <measurement group_id="B2" value="110.3" spread="26"/>
                    <measurement group_id="B3" value="110.6" spread="26.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL2-C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6" spread="2.3"/>
                    <measurement group_id="B2" value="6.2" spread="2.4"/>
                    <measurement group_id="B3" value="6.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>HDL3-C</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.5" spread="4.2"/>
                    <measurement group_id="B2" value="28.7" spread="4.1"/>
                    <measurement group_id="B3" value="28.6" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Apolipoprotein A-I</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="122.4" spread="16.2"/>
                    <measurement group_id="B2" value="123.7" spread="16.3"/>
                    <measurement group_id="B3" value="123.1" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Apolipoprotein B</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="83.2" spread="20.2"/>
                    <measurement group_id="B2" value="82.9" spread="20.7"/>
                    <measurement group_id="B3" value="83" spread="20.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lipoprotein (a)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77.3" spread="87.8"/>
                    <measurement group_id="B2" value="75.5" spread="89.6"/>
                    <measurement group_id="B3" value="76.4" spread="88.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Clinical History</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>History of myocardial infarction (MI)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="968"/>
                    <measurement group_id="B2" value="955"/>
                    <measurement group_id="B3" value="1923"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of CABG</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="600"/>
                    <measurement group_id="B2" value="627"/>
                    <measurement group_id="B3" value="1227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of Percutaneous Coronary Intervention</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1057"/>
                    <measurement group_id="B2" value="1044"/>
                    <measurement group_id="B3" value="2101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of stroke or cerebrovascular disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="358"/>
                    <measurement group_id="B2" value="362"/>
                    <measurement group_id="B3" value="720"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of peripheral vascular disease</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="234"/>
                    <measurement group_id="B2" value="231"/>
                    <measurement group_id="B3" value="465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Metabolic syndrome</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1414"/>
                    <measurement group_id="B2" value="1353"/>
                    <measurement group_id="B3" value="2767"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>History of diabetes (Type 1 or 2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="588"/>
                    <measurement group_id="B2" value="570"/>
                    <measurement group_id="B3" value="1158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Concomitant Medications at Baseline</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Statins</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1595"/>
                    <measurement group_id="B2" value="1601"/>
                    <measurement group_id="B3" value="3196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Beta-blockers</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1377"/>
                    <measurement group_id="B2" value="1342"/>
                    <measurement group_id="B3" value="2719"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ACE inhibitor or Angiotensin Receptor Blocker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1258"/>
                    <measurement group_id="B2" value="1271"/>
                    <measurement group_id="B3" value="2529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Aspirin or other antiplatelet or anticoagulant</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1680"/>
                    <measurement group_id="B2" value="1654"/>
                    <measurement group_id="B3" value="3334"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite End Point of CHD Death, Nonfatal MI, Ischemic Stroke, Hospitalization for Non-ST Segment Elevation Acute Coronary Syndrome (ACS), or Symptom-driven Coronary or Cerebral Revascularization</title>
        <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months.</time_frame>
        <population>Intention-to-treat</population>
        <group_list>
          <group group_id="O1">
            <title>ERN + Simvastatin</title>
            <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
          <group group_id="O2">
            <title>Placebo + Simvastatin</title>
            <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
        </group_list>
        <measure>
          <title>Composite End Point of CHD Death, Nonfatal MI, Ischemic Stroke, Hospitalization for Non-ST Segment Elevation Acute Coronary Syndrome (ACS), or Symptom-driven Coronary or Cerebral Revascularization</title>
          <population>Intention-to-treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1718"/>
                <count group_id="O2" value="1696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="282"/>
                    <measurement group_id="O2" value="274"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.80</p_value>
            <method>Regression, Cox</method>
            <method_desc>Adjusting for gender and history of diabetes (randomization stratification factors).</method_desc>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.21</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Endpoint of CHD Death, Non-fatal MI, High-risk ACS or Ischemic Stroke</title>
        <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ERN + Simvastatin</title>
            <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
          <group group_id="O2">
            <title>Placebo + Simvastatin</title>
            <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Endpoint of CHD Death, Non-fatal MI, High-risk ACS or Ischemic Stroke</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1718"/>
                <count group_id="O2" value="1696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="171"/>
                    <measurement group_id="O2" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.49</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.34</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Composite Endpoint of CHD Death, Non-fatal MI, or Ischemic Stroke</title>
        <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination) for an average of 36 months follow-up, maximum 66 months</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>ERN + Simvastatin</title>
            <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
          <group group_id="O2">
            <title>Placebo + Simvastatin</title>
            <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Endpoint of CHD Death, Non-fatal MI, or Ischemic Stroke</title>
          <population>Intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1718"/>
                <count group_id="O2" value="1696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                    <measurement group_id="O2" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.30</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.13</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.42</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiovascular Mortality</title>
        <time_frame>Time to first event measured from date of randomization through last follow-up visit (common termination), for an average of 36 months follow-up, maximum 66 months.</time_frame>
        <population>Intention to treat</population>
        <group_list>
          <group group_id="O1">
            <title>ERN + Simvastatin</title>
            <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
          <group group_id="O2">
            <title>Placebo + Simvastatin</title>
            <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiovascular Mortality</title>
          <population>Intention to treat</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1718"/>
                <count group_id="O2" value="1696"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.47</p_value>
            <method>Regression, Cox</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.17</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.76</ci_lower_limit>
            <ci_upper_limit>1.80</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Randomization through final study visit after recommendation to curtail study (June - September 2011)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ERN + Simvastatin</title>
          <description>Extended release niacin plus simvastatin
Extended release niacin: 2,000 mg/day or 1,500 mg/day if higher dose not tolerated
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
        <group group_id="E2">
          <title>Placebo + Simvastatin</title>
          <description>Simvastatin alone
Simvastatin: Dose adjusted to achieve LDL-C 40 mg/dL - 80 mg/dL, adding ezetimibe (10 mg/day) if needed to achieve LDL-C target</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="587" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="551" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chronic lymphocytic leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Iron deficiency anaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Leukopenia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aortic valve calcification</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aortic valve disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arrhythmia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arteriospasm coronary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="25" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrial flutter</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrial thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrioventricular block</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrioventricular block third degree</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bundle branch block right</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cor pulmonale</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cyanosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diastolic dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="31" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea paroxysmal nocturnal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intracardiac thrombus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ischaemic cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myocardial ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nodal rhythm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Palpitations</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pulmonary oedema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Restrictive cardiomyopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sick sinus syndrome</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sinus bradycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Subvalvular aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Supraventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tachycardia paroxysmal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tricuspid valve incompetence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ventricle rupture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ventricular dysfunction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ventricular extrasystoles</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ventricular tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal arteriovenous malformation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypospadias</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sickle cell anaemia with crisis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vestibular neuronitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Adrenal insufficiency</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia of malignancy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperthyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypothyroidism</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Chorioretinal atrophy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diplopia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Eye inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Optic ischaemic neuropathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Retinal detachment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vision blurred</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal adhesions</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal hernia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal pain lower</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abdominal strangulated hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Anal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aphthous stomatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colitis ischaemic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colonic fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colonic polyp</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Crohn's disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diarrhoea haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diverticulitis oesophageal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diverticulum intestinal haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Enteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Epigastric discomfort</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Faeces discoloured</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastric haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastroduodenitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrointestinal motility disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrointestinal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haematochezia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hiatus hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Inguinal hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Inguinal hernia, obstructive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intestinal ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Melaena</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Odynophagia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oesophageal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oesophageal ulcer haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oesophagitis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancreatic mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pharyngoesophageal diverticulum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rectal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rectal polyp</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Umbilical hernia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Volvulus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="20" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Abasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Adverse drug reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" subjects_affected="10" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chills</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Face oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Facial pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gait disturbance</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>General physical health deterioration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperthermia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypothermia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Influenza like illness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mass</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Multi-organ failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="12" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sudden death</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Thirst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Bile duct stone</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Biliary colic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gallbladder pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic congestion</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic function abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic lesion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperbilirubinaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic shock</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abscess intestinal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abscess limb</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arthritis bacterial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bacterial infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Biliary sepsis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bronchitis acute</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Enterocolitis infectious</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastroenteritis cryptosporidial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatitis B</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Incision site infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Infected insect bite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Liver abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lobar pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Localised infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Meningitis aseptic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Necrotising fasciitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oesophageal candidiasis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Perianal abscess</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia bacterial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia klebsiella</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia primary atypical</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia viral</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postoperative infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rectal abscess</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Septic embolus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Staphylococcal bacteraemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sweat gland infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Wound infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Accidental overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Anastomotic leak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Anastomotic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cervical vertebral fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Clavicle fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Excoriation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="9" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Foreign body trauma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Fracture of penis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hand fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Humerus fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Incision site complication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Incision site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Incisional hernia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Injury asphyxiation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intentional overdose</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Jaw fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Joint dislocation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Joint injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Joint sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lower limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Multiple drug overdose</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Multiple fractures</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Narcotic intoxication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pelvic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pharyngeal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Polytraumatism</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post laminectomy syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural bile leak</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural haematuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post procedural urine leak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postoperative fever</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postoperative renal failure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postoperative wound complication</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Radius fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rib fracture</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Skeletal injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Skin laceration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal fracture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Splenic injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Stent-graft endoleak</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Subdural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Traumatic brain injury</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Traumatic fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Traumatic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Traumatic intracranial haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Upper limb fracture</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Wound decomposition</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Arteriogram coronary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arteriogram coronary normal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aspartate aminotransferase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood creatinine increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood glucose decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cardiac stress test abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ejection fraction abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ejection fraction decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haematocrit decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haemoglobin decreased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Heart rate decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Heart rate increased</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic enzyme increased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>International normalised ratio increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intraocular pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oxygen consumption increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Prostatic specific antigen increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Transaminases increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Decreased appetite</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetes mellitus non-insulin-dependent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diabetic ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Electrolyte imbalance</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Fluid retention</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypercalcaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperkalaemia</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyponatraemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypovolaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malnutrition</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oral intake reduced</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bunion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bursitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cervical spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Foot deformity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haemarthrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intervertebral disc compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intervertebral disc disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Joint swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mobility decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Muscle twitching</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Musculoskeletal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Musculoskeletal stiffness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neuropathic arthropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Osteonecrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rhabdomyolysis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sensation of heaviness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spondylitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Synovial cyst</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tendonitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Acute myeloid leukaemia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Adenocarcinoma pancreas</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Basal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Benign neoplasm of ureter</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Benign salivary gland neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bladder cancer</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bladder cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bladder cancer stage IV</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bladder neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bone cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bone neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Brain neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Brain neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Breast cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Breast cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the caecum</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Carcinoid tumour of the gastrointestinal tract</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Choroid melanoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colon adenoma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Colon cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Endometrial cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastric cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrointestinal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gastrointestinal stromal tumour</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Glioblastoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hepatic neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypopharyngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Laryngeal cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung adenocarcinoma metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung squamous cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malignant lymphoid neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malignant melanoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malignant palate neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Malignant urinary tract neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Melanocytic naevus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Meningioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mesothelioma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Metastases to central nervous system</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Metastatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Metastatic renal cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Metastatic squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Multiple myeloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myelodysplastic syndrome</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neoplasm prostate</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-Hodgkin's lymphoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage I</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-small cell lung cancer stage IIIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oesophageal carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancreatic carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pancreatic neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pituitary tumour benign</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Prostate cancer</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Prostate cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rectal adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal cancer metastatic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage II</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal cell carcinoma stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Salivary gland cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Skin cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Small intestine carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal cord neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Squamous cell carcinoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Testis cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Thyroid cancer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tongue neoplasm malignant stage unspecified</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tonsillar neoplasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Amnesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aphasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Balance disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cerebral haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cervicobrachial syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Coordination abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dementia Alzheimer's type</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Depressed level of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Drooling</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dysarthria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Essential tremor</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Facial palsy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haemorrhage intracranial</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hemiparesis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intracranial aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lumbar radiculopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Migraine with aura</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myelitis transverse</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myoclonus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nerve compression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neuritis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Normal pressure hydrocephalus</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Paresis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Parkinson's disease</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post herpetic neuralgia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Radicular pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Simple partial seizures</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal claudication</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Subarachnoid haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Syncope vasovagal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Transient ischaemic attack</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Alcohol withdrawal syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Anger</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bipolar I disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Confusional state</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Depression suicidal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Depressive symptom</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dysphasia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hallucination</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Impaired self-care</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Major depression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mental disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Panic attack</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Post-traumatic stress disorder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Psychotic disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute prerenal failure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Calculus ureteric</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Calculus urinary</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cystitis haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dysuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Glomerulonephritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hydronephrosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neurogenic bladder</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Obstructive uropathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pollakiuria</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pyuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal colic</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal cyst</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal failure acute</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Renal failure chronic</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Stress urinary incontinence</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ureteric obstruction</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Ureteric stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urethral obstruction</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urethral perforation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urinary bladder haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urinary retention</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Benign prostatic hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Breast cancer in situ</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Endometrial cancer recurrent</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pelvic haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pelvic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Penile pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Postmenopausal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Prostatitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vaginal haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cryptogenic organising pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diaphragmatic paralysis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dysphonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haemoptysis</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypercapnia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Idiopathic pulmonary fibrosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Interstitial lung disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Laryngeal oedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Lung infiltration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nasal septum deviation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Orthopnoea</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pharyngolaryngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pleurisy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pleuritic pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Productive cough</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Respiratory acidosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Respiratory distress</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sleep apnoea syndrome</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Throat tightness</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioneurotic oedema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dermatitis contact</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hyperhidrosis</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia facial</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rash pruritic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Cardioversion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Coronary revascularisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypotensive anaesthesia procedure</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Peripheral revascularisation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Shoulder arthroplasty</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Spinal decompression</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Stent placement</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Therapeutic embolisation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Toe amputation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aortic aneurysm rupture</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Aorto-duodenal fistula</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Carotid artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Carotid artery disease</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Carotid artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Circulatory collapse</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Deep vein thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Femoral arterial stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Flushing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Iliac artery stenosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Intermittent claudication</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Peripheral artery aneurysm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Peripheral ischaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Shock haemorrhagic</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vascular pseudoaneurysm</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vasospasm</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MedDRA (15.0)</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1413" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="1345" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="41" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="46" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="43" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="95" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" subjects_affected="89" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="89" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Dyspnoea exertional</sub_title>
                <counts group_id="E1" subjects_affected="26" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Cataract</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="77" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="39" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="34" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="136" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="63" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="55" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="40" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="87" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="74" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="42" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Oedema peripheral</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="73" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="82" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="68" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="30" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Herpes zoster</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="29" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="62" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="113" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="121" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="80" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="71" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="72" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="60" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="29" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="36" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood glucose increased</sub_title>
                <counts group_id="E1" subjects_affected="112" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="78" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus</sub_title>
                <counts group_id="E1" subjects_affected="67" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="65" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="138" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="158" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="120" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="122" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="75" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="88" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="53" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="53" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="38" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Osteoarthritis</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="50" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="134" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="147" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="95" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="122" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="61" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="51" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Hypoaesthesia</sub_title>
                <counts group_id="E1" subjects_affected="36" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="35" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="57" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="52" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="47" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="27" subjects_at_risk="1696"/>
              </event>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="58" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="38" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" subjects_affected="59" subjects_at_risk="1718"/>
                <counts group_id="E2" subjects_affected="58" subjects_at_risk="1696"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ruth McBride</name_or_title>
      <organization>Axio Research, LLC</organization>
      <phone>206-577-0212</phone>
      <email>ruthm@axioresearch.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

